Stocktoria
TENET HEALTHCARE CORP THC
TENET HEALTHCARE CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.3B | $20.7B | $20.6B | $19.2B | $19.5B | $17.6B | $18.5B | $18.3B | $20.6B | $21.1B |
| Operating income | $3.5B | $6.0B | $2.5B | $2.3B | $2.9B | $2.0B | $1.5B | $1.6B | $1.1B | $1.2B |
| Interest expense | — | — | $901.0M | $890.0M | $923.0M | $1.0B | $985.0M | $1.0B | $1.0B | $979.0M |
| Income tax | $433.0M | $1.2B | $306.0M | $344.0M | $411.0M | -$97.0M | $160.0M | $173.0M | $219.0M | $67.0M |
| Operating cash flow | $3.5B | $2.0B | $2.4B | $1.1B | $1.6B | $3.4B | $1.2B | $1.0B | $1.2B | $558.0M |
| Free cash flow | $2.5B | $1.1B | $1.6B | $321.0M | $910.0M | $2.9B | $563.0M | $432.0M | $493.0M | -$317.0M |
| Cash & equivalents | $2.9B | $3.0B | $1.2B | $858.0M | $2.4B | $2.4B | $262.0M | $411.0M | $611.0M | $716.0M |
| Inventory | $348.0M | $346.0M | $411.0M | $405.0M | $384.0M | $368.0M | $310.0M | $305.0M | $289.0M | $326.0M |
| Total assets | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B | $27.1B | $23.4B | $22.4B | $23.4B | $24.7B |
| Total liabilities | $20.7B | $20.4B | $22.8B | $22.5B | $23.3B | $24.2B | $21.4B | $20.3B | $21.0B | $21.2B |
| Shareholders' equity | $6.0B | $5.8B | $3.1B | $2.5B | $2.1B | $937.0M | $437.0M | $624.0M | $483.0M | $1.1B |
| EPS (diluted) | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 | $-2.08 | $1.00 | $-7.00 | $-1.93 |
Growth · year-over-year · Revenue CAGR 0.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +3.1% | +0.5% | +7.2% | -1.6% | +10.5% | -4.5% | +0.9% | -11.2% | -2.2% | — |
| EPS growth | -52.6% | +472.7% | +50.7% | -55.0% | +124.5% | — | -308.0% | — | — | — |
| Free cash flow growth | +126.7% | -31.2% | +405.6% | -64.7% | -68.3% | +409.2% | +30.3% | -12.4% | — | -272.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.